Barbara Bhatt

Barbara Bhatt investigates the optimal management of low-risk differentiated thyroid cancer in the context of widespread thyroid cancer overdiagnosis. Her research has evaluated the oncological safety of active surveillance as an alternative to immediate surgery for low-risk papillary microcarcinoma, contributing to the evidence supporting this approach in selected patients. She has characterized clinical and molecular factors that predict low versus high risk of progression in patients undergoing surveillance. Her work addresses the epidemic of thyroid cancer overdiagnosis and overtreatment and informs guidelines for appropriately de-escalating management of low-risk thyroid cancers without compromising patient outcomes.